There are many unsolved problems in the study of cancer screening: how to estimate key parameters involved in screening exams, such as screening sensitivity; how to estimate distribution of lead time; how to evaluate the long-term effects of screening, including probability of over diagnosis, true-early-detection and no-early-detection, etc.
Cancer screening has been carried out for six decades – however, there are many unsolved problems: how to estimate key parameters involved in screenings, such as sensitivity, the time duration in the preclinical state (i.e., sojourn time), and time duration in the disease-free state; how to estimate the distribution of lead time, the diagnosis time advanced by screening; how to evaluate the long-term outcomes of screening, including the probability of overdiagnosis among the screen-detected; when to schedule the first exam based on one’s current age and risk tolerance; and when to schedule the upcoming exam based on one’s screening history, age, and risk tolerance. These problems need proper probability models and statistical methods in order to be dealt with.
Features:
This book gives a concise account of the analysis of cancer screening data, using probability models and statistical methods.
Real data sets are provided so that cancer researchers and statisticians can apply the methods in the learning process.
It develops statistical methods in the commonly used disease progressive model.
It provides solutions to practical problems and introduces open problems.
It provides a framework for the most recent developments based on the author’s research.
The book is primarily aimed at researchers and practitioners from biostatistics and cancer research. Readers should have the prerequisite knowledge of calculus, probability, and statistical inference. The book could be used as a one-semester textbook on the topic of cancer screening methodology for a graduate-level course.
Negatief, positief, neutraal: we zetten een review altijd online. We controleren wel eerst of ’ie voldoet aan onze reviewvoorwaarden en niet nep is. We controleren ook of ’ie is geschreven door iemand die het artikel heeft gekocht via bol.com en zetten dit er dan bij. De controles gebeuren automatisch, al kijken er soms mensen mee. Bol.com betaalt niet voor reviews. Als een reviewer door een andere partij is vergoed, staat dit in de review zelf.
Kies gewenste uitvoering
Bindwijze
: Hardcover
Prijsinformatie en bestellen
De prijs van dit product is 110 euro en 99 cent.110
99
2 - 3 weken
Levertijd
We doen er alles aan om dit artikel op tijd te bezorgen. Het is echter in een enkel geval mogelijk dat door omstandigheden de bezorging vertraagd is.
Bezorgopties
We bieden verschillende opties aan voor het bezorgen of ophalen van je bestelling. Welke opties voor jouw bestelling beschikbaar zijn, zie je bij het afronden van de bestelling.
Verkoop door bol
Chapman & Hall/CRC Biostatistics Series- Probability Modeling and Statistical Inference in Cancer Screening
